Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Clinical trial NCT00346216 · COMPLETED
Trial details
- NCT number
- NCT00346216
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-04
- Primary completion
- 2016-04-12
- Enrollment
- 24081
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.